Published in Eur Heart J on September 01, 2000
Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway. J Cell Biol (2008) 2.08
Brugada syndrome. Orphanet J Rare Dis (2006) 0.84
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res (2000) 3.68
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J (2001) 3.02
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation (1988) 2.86
Cardiac conduction defects associate with mutations in SCN5A. Nat Genet (1999) 2.73
A sodium-channel mutation causes isolated cardiac conduction disease. Nature (2001) 2.67
Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol (2001) 2.57
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ Res (2000) 2.17
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J (2002) 2.17
Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol (1990) 2.05
A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med (2000) 2.02
De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation (2001) 1.88
Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem (2001) 1.78
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol (2000) 1.74
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel. Circ Res (2001) 1.72
Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol (2001) 1.71
LocaLisa: new technique for real-time 3-dimensional localization of regular intracardiac electrodes. Circulation (1999) 1.71
Molecular diagnosis in a child with sudden infant death syndrome. Lancet (2001) 1.66
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J (2000) 1.59
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Persistent precordial "hyperacute" T-waves signify proximal left anterior descending artery occlusion. Heart (2009) 1.51
Inferior vena cava loop of the implantable cardioverter defibrillator endocardial lead: a possible solution of the growth problem in pediatric implantation. Pacing Clin Electrophysiol (2000) 1.48
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet (1999) 1.46
Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J Am Coll Cardiol (2001) 1.46
Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum Mol Genet (1999) 1.43
Changes in conduction velocity during acute ischemia in ventricular myocardium of the isolated porcine heart. Circulation (1986) 1.42
Brugada syndrome and sudden cardiac death in children. Lancet (2000) 1.40
Persisting zones of slow impulse conduction in developing chicken hearts. Circ Res (1992) 1.37
The subendocardial border zone during acute ischemia of the rabbit heart: an electrophysiologic, metabolic, and morphologic correlative study. Circulation (1986) 1.35
Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res (1999) 1.34
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord (1999) 1.32
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Mechanisms of I(Ks) suppression in LQT1 mutants. Am J Physiol Heart Circ Physiol (2000) 1.24
Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Circulation (2001) 1.22
Protective effect of vagal stimulation on reperfusion arrhythmias in cats. Circ Res (1987) 1.20
Morphology of electrophysiologically identified junctions between Purkinje fibers and ventricular muscle in rabbit and pig hearts. Circ Res (1991) 1.14
Premature ventricular contractions during triggered imaging with ultrasound contrast. J Am Soc Echocardiogr (2000) 1.12
Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol (2001) 1.12
Adenosine induced ventricular arrhythmias in the emergency room. Pacing Clin Electrophysiol (2001) 1.11
Cardiac sodium channel and inherited arrhythmia syndromes. Cardiovasc Res (2001) 1.10
Major achievements in cardiology in the past century: influence on Dutch cardiovascular medicine. Neth Heart J (2009) 1.07
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis (2013) 1.01
Torsade de pointes. Mechanisms and management. Drugs (1994) 1.01
Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am J Physiol Heart Circ Physiol (2000) 1.00
Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol (1997) 0.98
Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity. Eur J Hum Genet (2007) 0.97
Journal metrics for the Netherlands Heart Journal. Neth Heart J (2011) 0.92
Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum Mutat (1999) 0.92
Predicting the long-QT genotype from clinical data: from sense to science. Circulation (2000) 0.90
Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J (2011) 0.89
Molecular mechanisms of arrhythmias. Rev Port Cardiol (1998) 0.88
Long-term (subacute) potassium treatment in congenital HERG-related long QT syndrome (LQTS2). J Cardiovasc Electrophysiol (1999) 0.87
The combined effects of hypoxia, high K+, and acidosis on the intracellular sodium activity and resting potential in guinea pig papillary muscle. Circ Res (1986) 0.85
Genomic organisation and chromosomal localisation of two members of the KCND ion channel family, KCND2 and KCND3. Hum Genet (2000) 0.85
Exploring the hidden danger of noncardiac drugs. J Cardiovasc Electrophysiol (1998) 0.85
The long QT syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene. Hum Genet (1997) 0.85
Drug-induced J point elevation: a marker for genetic risk of sudden death or ECG curiosity? J Cardiovasc Electrophysiol (1999) 0.84
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents. J Am Coll Cardiol (1995) 0.83
KATP channel openers, myocardial ischemia, and arrhythmias--should the electrophysiologist worry? Cardiovasc Drugs Ther (2000) 0.82
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. Hong Kong Med J (2004) 0.80
Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation (1999) 0.80
Vancomycin does not enhance hypotension under anesthesia. Anesth Analg (1993) 0.80
LQT genotype-phenotype relationships: patients and patches. Cardiovasc Res (2001) 0.80
Sulfonylurea derivatives in cardiovascular research and in cardiovascular patients. Cardiovasc Res (1997) 0.79
[Sudden death in young men due to arrhythmogenic right ventricular dysplasia]. Ned Tijdschr Geneeskd (1998) 0.79
Suppression of torsades de pointes by atropine. Heart (1998) 0.78
[Long QT-interval syndrome and investigation of heritability: psychological reactions in three generations in one family]. Ned Tijdschr Geneeskd (2000) 0.78
K(ATP) channel opening during ischemia: effects on myocardial noradrenaline release and ventricular arrhythmias. J Cardiovasc Pharmacol (2001) 0.77
T wave alternans after sotalol: evidence for increased sensitivity to sotalol after conversion from atrial fibrillation to sinus rhythm. Heart (1998) 0.77
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]. Ital Heart J Suppl (2001) 0.77
From catheters to vectors: the dawn of molecular electrophysiology. Nat Med (2000) 0.76
Efficacy of diltiazem in two experimental feline models of sudden cardiac death. J Am Coll Cardiol (1986) 0.76
Cardiovascular safety of second-generation antihistamines. Am J Rhinol (1999) 0.76
Learning from mistakes: the case of clinical electrophysiology: a perspective on evidence-based rhythmology. Circulation (2001) 0.76
Foretelling the future in Brugada syndrome: do we have the crystal ball? J Cardiovasc Electrophysiol (2001) 0.76
[Catecholinergic ventricular tachycardia in children]. Arch Mal Coeur Vaiss (2005) 0.75
Is long QT syndrome entering the era of molecular diagnosis? Heart (1997) 0.75
What we can learn from individual resuscitated patients. Cardiovasc Res (2000) 0.75
A new, sympathetic look at KATP channels in the heart. Cardiovasc Res (1999) 0.75
Dronedarone in patients with atrial fibrillation. Neth Heart J (2010) 0.75
ATP and the role of IK.ATP during acute myocardial ischemia: controversies revive. Cardiovasc Res (1997) 0.75
[Iatrogenic collapse; can this be prevented?]. Ned Tijdschr Geneeskd (1997) 0.75
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias. Eur Heart J (1988) 0.75
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. Cardiologia (1995) 0.75
[The heartache of muscular dystrophy]. Ned Tijdschr Geneeskd (2000) 0.75
[Truth after death; autopsies as a valued investigative tool]. Ned Tijdschr Geneeskd (2000) 0.75
[Genetic basis of sudden cardiac death]. Recenti Prog Med (2000) 0.75
Regulation of intracellular sodium ions in acute reversible myocardial ischemia--a perspective. J Mol Cell Cardiol (1986) 0.75
Significance of QT dispersion in the long QT syndrome. Prog Cardiovasc Dis (2000) 0.75
Left cardiac sympathetic denervation in long QT syndrome patients. J Interv Cardiol (1995) 0.75
Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-up. Am Heart J (1989) 0.75